#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0057] The above steps may be accelerated by adding an enhancer, a surfactant, or both to the solutions used in the process.
1-1	0-1	[	_	_	
1-2	1-5	0057	_	_	
1-3	5-6	]	_	_	
1-4	7-10	The	_	_	
1-5	11-16	above	_	_	
1-6	17-22	steps	_	_	
1-7	23-26	may	_	_	
1-8	27-29	be	_	_	
1-9	30-41	accelerated	_	_	
1-10	42-44	by	_	_	
1-11	45-51	adding	_	_	
1-12	52-54	an	_	_	
1-13	55-63	enhancer	_	_	
1-14	63-64	,	_	_	
1-15	65-66	a	_	_	
1-16	67-77	surfactant	_	_	
1-17	77-78	,	_	_	
1-18	79-81	or	_	_	
1-19	82-86	both	_	_	
1-20	87-89	to	_	_	
1-21	90-93	the	_	_	
1-22	94-103	solutions	_	_	
1-23	104-108	used	_	_	
1-24	109-111	in	_	_	
1-25	112-115	the	_	_	
1-26	116-123	process	_	_	
1-27	123-124	.	_	_	

#Text=The enhancer may be polyethylene glycol (PEG), mono- and dimethyleneglycol, propylene glycol, polyvinyl pyrrolidone, or the like; the polymer used may be between about 100 and about 500 average molecular weight, preferably about 300 molecular weight.
2-1	125-128	The	_	_	
2-2	129-137	enhancer	_	_	
2-3	138-141	may	_	_	
2-4	142-144	be	_	_	
2-5	145-157	polyethylene	_	_	
2-6	158-164	glycol	_	_	
2-7	165-166	(	_	_	
2-8	166-169	PEG	_	_	
2-9	169-170	)	_	_	
2-10	170-171	,	_	_	
2-11	172-176	mono	_	_	
2-12	176-177	-	_	_	
2-13	178-181	and	_	_	
2-14	182-199	dimethyleneglycol	_	_	
2-15	199-200	,	_	_	
2-16	201-210	propylene	_	_	
2-17	211-217	glycol	_	_	
2-18	217-218	,	_	_	
2-19	219-228	polyvinyl	_	_	
2-20	229-240	pyrrolidone	_	_	
2-21	240-241	,	_	_	
2-22	242-244	or	_	_	
2-23	245-248	the	_	_	
2-24	249-253	like	_	_	
2-25	253-254	;	_	_	
2-26	255-258	the	_	_	
2-27	259-266	polymer	_	_	
2-28	267-271	used	_	_	
2-29	272-275	may	_	_	
2-30	276-278	be	_	_	
2-31	279-286	between	_	_	
2-32	287-292	about	_	_	
2-33	293-296	100	_	_	
2-34	297-300	and	_	_	
2-35	301-306	about	_	_	
2-36	307-310	500	_	_	
2-37	311-318	average	_	_	
2-38	319-328	molecular	_	_	
2-39	329-335	weight	_	_	
2-40	335-336	,	_	_	
2-41	337-347	preferably	_	_	
2-42	348-353	about	_	_	
2-43	354-357	300	_	_	
2-44	358-367	molecular	_	_	
2-45	368-374	weight	_	_	
2-46	374-375	.	_	_	

#Text=The surfactant may be dimethyl sulfoxide (DMSO), polyoxyethylene sorbitan esters (e.g., TWEEN 80), sodium dimethyl sulfosuccinate, mild household detergents, or the like.
#Text=[0058] Fixation initiates hardening of the tissue specimen, and may preserve cell morphology by stabilizing proteins and halting cellular degradation.
3-1	376-379	The	_	_	
3-2	380-390	surfactant	_	_	
3-3	391-394	may	_	_	
3-4	395-397	be	_	_	
3-5	398-406	dimethyl	_	_	
3-6	407-416	sulfoxide	_	_	
3-7	417-418	(	_	_	
3-8	418-422	DMSO	_	_	
3-9	422-423	)	_	_	
3-10	423-424	,	_	_	
3-11	425-440	polyoxyethylene	_	_	
3-12	441-449	sorbitan	_	_	
3-13	450-456	esters	_	_	
3-14	457-458	(	_	_	
3-15	458-461	e.g	_	_	
3-16	461-462	.	_	_	
3-17	462-463	,	_	_	
3-18	464-469	TWEEN	_	_	
3-19	470-472	80	_	_	
3-20	472-473	)	_	_	
3-21	473-474	,	_	_	
3-22	475-481	sodium	_	_	
3-23	482-490	dimethyl	_	_	
3-24	491-505	sulfosuccinate	_	_	
3-25	505-506	,	_	_	
3-26	507-511	mild	_	_	
3-27	512-521	household	_	_	
3-28	522-532	detergents	_	_	
3-29	532-533	,	_	_	
3-30	534-536	or	_	_	
3-31	537-540	the	_	_	
3-32	541-545	like	_	_	
3-33	545-546	.	_	_	
3-34	547-548	[	_	_	
3-35	548-552	0058	_	_	
3-36	552-553	]	_	_	
3-37	554-562	Fixation	_	_	
3-38	563-572	initiates	_	_	
3-39	573-582	hardening	_	_	
3-40	583-585	of	_	_	
3-41	586-589	the	_	_	
3-42	590-596	tissue	_	_	
3-43	597-605	specimen	_	_	
3-44	605-606	,	_	_	
3-45	607-610	and	_	_	
3-46	611-614	may	_	_	
3-47	615-623	preserve	_	_	
3-48	624-628	cell	_	_	
3-49	629-639	morphology	_	_	
3-50	640-642	by	_	_	
3-51	643-654	stabilizing	_	_	
3-52	655-663	proteins	_	_	
3-53	664-667	and	_	_	
3-54	668-675	halting	_	_	
3-55	676-684	cellular	_	_	
3-56	685-696	degradation	_	_	
3-57	696-697	.	_	_	

#Text=Without chemical fixation, endogenous enzymes will catabolize and lyse the cell, and the tissue micro-anatomy will be altered.
4-1	698-705	Without	_	_	
4-2	706-714	chemical	_	_	
4-3	715-723	fixation	_	_	
4-4	723-724	,	_	_	
4-5	725-735	endogenous	_	_	
4-6	736-743	enzymes	_	_	
4-7	744-748	will	_	_	
4-8	749-759	catabolize	_	_	
4-9	760-763	and	_	_	
4-10	764-768	lyse	_	_	
4-11	769-772	the	_	_	
4-12	773-777	cell	_	_	
4-13	777-778	,	_	_	
4-14	779-782	and	_	_	
4-15	783-786	the	_	_	
4-16	787-793	tissue	_	_	
4-17	794-807	micro-anatomy	_	_	
4-18	808-812	will	_	_	
4-19	813-815	be	_	_	
4-20	816-823	altered	_	_	
4-21	823-824	.	_	_	

#Text=The fixative may be a ketone (e.g., acetone, methyl ethyl ketone); aldehyde (e.g., acetylaldehyde, formaldehyde, glutaraldehyde, glyoxal); alcohol (e.g., methanol, ethanol, isopropanol); acetic acid; heavy metals (e.g., lead acetates and citrate, mercuric salts, chromic acid and its salts, picric acid, osmium tetroxide); or the like.
5-1	825-828	The	_	_	
5-2	829-837	fixative	_	_	
5-3	838-841	may	_	_	
5-4	842-844	be	_	_	
5-5	845-846	a	_	_	
5-6	847-853	ketone	_	_	
5-7	854-855	(	_	_	
5-8	855-858	e.g	_	_	
5-9	858-859	.	_	_	
5-10	859-860	,	_	_	
5-11	861-868	acetone	_	_	
5-12	868-869	,	_	_	
5-13	870-876	methyl	_	_	
5-14	877-882	ethyl	_	_	
5-15	883-889	ketone	_	_	
5-16	889-890	)	_	_	
5-17	890-891	;	_	_	
5-18	892-900	aldehyde	_	_	
5-19	901-902	(	_	_	
5-20	902-905	e.g	_	_	
5-21	905-906	.	_	_	
5-22	906-907	,	_	_	
5-23	908-922	acetylaldehyde	_	_	
5-24	922-923	,	_	_	
5-25	924-936	formaldehyde	_	_	
5-26	936-937	,	_	_	
5-27	938-952	glutaraldehyde	_	_	
5-28	952-953	,	_	_	
5-29	954-961	glyoxal	_	_	
5-30	961-962	)	_	_	
5-31	962-963	;	_	_	
5-32	964-971	alcohol	_	_	
5-33	972-973	(	_	_	
5-34	973-976	e.g	_	_	
5-35	976-977	.	_	_	
5-36	977-978	,	_	_	
5-37	979-987	methanol	_	_	
5-38	987-988	,	_	_	
5-39	989-996	ethanol	_	_	
5-40	996-997	,	_	_	
5-41	998-1009	isopropanol	_	_	
5-42	1009-1010	)	_	_	
5-43	1010-1011	;	_	_	
5-44	1012-1018	acetic	_	_	
5-45	1019-1023	acid	_	_	
5-46	1023-1024	;	_	_	
5-47	1025-1030	heavy	_	_	
5-48	1031-1037	metals	_	_	
5-49	1038-1039	(	_	_	
5-50	1039-1042	e.g	_	_	
5-51	1042-1043	.	_	_	
5-52	1043-1044	,	_	_	
5-53	1045-1049	lead	_	_	
5-54	1050-1058	acetates	_	_	
5-55	1059-1062	and	_	_	
5-56	1063-1070	citrate	_	_	
5-57	1070-1071	,	_	_	
5-58	1072-1080	mercuric	_	_	
5-59	1081-1086	salts	_	_	
5-60	1086-1087	,	_	_	
5-61	1088-1095	chromic	_	_	
5-62	1096-1100	acid	_	_	
5-63	1101-1104	and	_	_	
5-64	1105-1108	its	_	_	
5-65	1109-1114	salts	_	_	
5-66	1114-1115	,	_	_	
5-67	1116-1122	picric	_	_	
5-68	1123-1127	acid	_	_	
5-69	1127-1128	,	_	_	
5-70	1129-1135	osmium	_	_	
5-71	1136-1145	tetroxide	_	_	
5-72	1145-1146	)	_	_	
5-73	1146-1147	;	_	_	
5-74	1148-1150	or	_	_	
5-75	1151-1154	the	_	_	
5-76	1155-1159	like	_	_	
5-77	1159-1160	.	_	_	

#Text=Indications that fixation was inadequate can include: disassociation of tissue structures, bubbles in tissue sections, poor and irregular staining, shrunken cells, clumping of cytoplasm, condensation and less distinct nuclear chromatin, and autolysis/hemolysis of erythrocytes.
6-1	1161-1172	Indications	_	_	
6-2	1173-1177	that	_	_	
6-3	1178-1186	fixation	_	_	
6-4	1187-1190	was	_	_	
6-5	1191-1201	inadequate	_	_	
6-6	1202-1205	can	_	_	
6-7	1206-1213	include	_	_	
6-8	1213-1214	:	_	_	
6-9	1215-1229	disassociation	_	_	
6-10	1230-1232	of	_	_	
6-11	1233-1239	tissue	_	_	
6-12	1240-1250	structures	_	_	
6-13	1250-1251	,	_	_	
6-14	1252-1259	bubbles	_	_	
6-15	1260-1262	in	_	_	
6-16	1263-1269	tissue	_	_	
6-17	1270-1278	sections	_	_	
6-18	1278-1279	,	_	_	
6-19	1280-1284	poor	_	_	
6-20	1285-1288	and	_	_	
6-21	1289-1298	irregular	_	_	
6-22	1299-1307	staining	_	_	
6-23	1307-1308	,	_	_	
6-24	1309-1317	shrunken	_	_	
6-25	1318-1323	cells	_	_	
6-26	1323-1324	,	_	_	
6-27	1325-1333	clumping	_	_	
6-28	1334-1336	of	_	_	
6-29	1337-1346	cytoplasm	_	_	
6-30	1346-1347	,	_	_	
6-31	1348-1360	condensation	_	_	
6-32	1361-1364	and	_	_	
6-33	1365-1369	less	_	_	
6-34	1370-1378	distinct	_	_	
6-35	1379-1386	nuclear	_	_	
6-36	1387-1396	chromatin	_	_	
6-37	1396-1397	,	_	_	
6-38	1398-1401	and	_	_	
6-39	1402-1411	autolysis	_	_	
6-40	1411-1412	/	_	_	
6-41	1412-1421	hemolysis	_	_	
6-42	1422-1424	of	_	_	
6-43	1425-1437	erythrocytes	_	_	
6-44	1437-1438	.	_	_	

#Text=Generally, fixation with acetone is accomplished on a time scale of minutes instead of hours because long exposure turns tissue brittle and causes extreme shrinkage.
7-1	1439-1448	Generally	_	_	
7-2	1448-1449	,	_	_	
7-3	1450-1458	fixation	_	_	
7-4	1459-1463	with	_	_	
7-5	1464-1471	acetone	_	_	
7-6	1472-1474	is	_	_	
7-7	1475-1487	accomplished	_	_	
7-8	1488-1490	on	_	_	
7-9	1491-1492	a	_	_	
7-10	1493-1497	time	_	_	
7-11	1498-1503	scale	_	_	
7-12	1504-1506	of	_	_	
7-13	1507-1514	minutes	_	_	
7-14	1515-1522	instead	_	_	
7-15	1523-1525	of	_	_	
7-16	1526-1531	hours	_	_	
7-17	1532-1539	because	_	_	
7-18	1540-1544	long	_	_	
7-19	1545-1553	exposure	_	_	
7-20	1554-1559	turns	_	_	
7-21	1560-1566	tissue	_	_	
7-22	1567-1574	brittle	_	_	
7-23	1575-1578	and	_	_	
7-24	1579-1585	causes	_	_	
7-25	1586-1593	extreme	_	_	
7-26	1594-1603	shrinkage	_	_	
7-27	1603-1604	.	_	_	

#Text=Further contrasting with conventional fixation using formalin, use of ketones and alcohol is believed to act as fixatives by physically stabilizing proteins (e.g., precipitation) without chemically combining with them.
#Text=[0059] Dehydration removes water from the tissue specimen to promote hardening.
8-1	1605-1612	Further	_	_	
8-2	1613-1624	contrasting	_	_	
8-3	1625-1629	with	_	_	
8-4	1630-1642	conventional	_	_	
8-5	1643-1651	fixation	_	_	
8-6	1652-1657	using	_	_	
8-7	1658-1666	formalin	_	_	
8-8	1666-1667	,	_	_	
8-9	1668-1671	use	_	_	
8-10	1672-1674	of	_	_	
8-11	1675-1682	ketones	_	_	
8-12	1683-1686	and	_	_	
8-13	1687-1694	alcohol	_	_	
8-14	1695-1697	is	_	_	
8-15	1698-1706	believed	_	_	
8-16	1707-1709	to	_	_	
8-17	1710-1713	act	_	_	
8-18	1714-1716	as	_	_	
8-19	1717-1726	fixatives	_	_	
8-20	1727-1729	by	_	_	
8-21	1730-1740	physically	_	_	
8-22	1741-1752	stabilizing	_	_	
8-23	1753-1761	proteins	_	_	
8-24	1762-1763	(	_	_	
8-25	1763-1766	e.g	_	_	
8-26	1766-1767	.	_	_	
8-27	1767-1768	,	_	_	
8-28	1769-1782	precipitation	_	_	
8-29	1782-1783	)	_	_	
8-30	1784-1791	without	_	_	
8-31	1792-1802	chemically	_	_	
8-32	1803-1812	combining	_	_	
8-33	1813-1817	with	_	_	
8-34	1818-1822	them	_	_	
8-35	1822-1823	.	_	_	
8-36	1824-1825	[	_	_	
8-37	1825-1829	0059	_	_	
8-38	1829-1830	]	_	_	
8-39	1831-1842	Dehydration	_	_	
8-40	1843-1850	removes	_	_	
8-41	1851-1856	water	_	_	
8-42	1857-1861	from	_	_	
8-43	1862-1865	the	_	_	
8-44	1866-1872	tissue	_	_	
8-45	1873-1881	specimen	_	_	
8-46	1882-1884	to	_	_	
8-47	1885-1892	promote	_	_	
8-48	1893-1902	hardening	_	_	
8-49	1902-1903	.	_	_	

#Text=Replacement of water in the tissue specimen with a dehydrating agent also facilitates subsequent replacement of the dehydrating agent with material used for impregnation.
9-1	1904-1915	Replacement	*[1]	10-1[2_1]	
9-2	1916-1918	of	*[1]	_	
9-3	1919-1924	water	*[1]	_	
9-4	1925-1927	in	*[1]	_	
9-5	1928-1931	the	*[1]	_	
9-6	1932-1938	tissue	*[1]	_	
9-7	1939-1947	specimen	*[1]	_	
9-8	1948-1952	with	*[1]	_	
9-9	1953-1954	a	*[1]	_	
9-10	1955-1966	dehydrating	*[1]	_	
9-11	1967-1972	agent	*[1]	_	
9-12	1973-1977	also	*[1]	_	
9-13	1978-1989	facilitates	*[1]	_	
9-14	1990-2000	subsequent	*[1]	_	
9-15	2001-2012	replacement	*[1]	_	
9-16	2013-2015	of	*[1]	_	
9-17	2016-2019	the	*[1]	_	
9-18	2020-2031	dehydrating	*[1]	_	
9-19	2032-2037	agent	*[1]	_	
9-20	2038-2042	with	*[1]	_	
9-21	2043-2051	material	*[1]	_	
9-22	2052-2056	used	*[1]	_	
9-23	2057-2060	for	*[1]	_	
9-24	2061-2073	impregnation	*[1]	_	
9-25	2073-2074	.	*[1]	_	

#Text=This solution exchange is enhanced by using a volatile solvent for dehydration.
10-1	2075-2079	This	*[2]	_	
10-2	2080-2088	solution	*[2]	_	
10-3	2089-2097	exchange	_	_	
10-4	2098-2100	is	_	_	
10-5	2101-2109	enhanced	_	_	
10-6	2110-2112	by	_	_	
10-7	2113-2118	using	_	_	
10-8	2119-2120	a	_	_	
10-9	2121-2129	volatile	_	_	
10-10	2130-2137	solvent	_	_	
10-11	2138-2141	for	_	_	
10-12	2142-2153	dehydration	_	_	
10-13	2153-2154	.	_	_	

#Text=The dehydrating agent may be low molecular weight alcohols (e.g., methanol, isopropanol, ethanol, propanol, butanol, isobutanol, ethyl butanol, amyl alcohol), ketones, dioxane, alkylene glycols, ethylene glycol, or polyalkylene glycols.
11-1	2155-2158	The	_	_	
11-2	2159-2170	dehydrating	_	_	
11-3	2171-2176	agent	_	_	
11-4	2177-2180	may	_	_	
11-5	2181-2183	be	_	_	
11-6	2184-2187	low	_	_	
11-7	2188-2197	molecular	_	_	
11-8	2198-2204	weight	_	_	
11-9	2205-2213	alcohols	_	_	
11-10	2214-2215	(	_	_	
11-11	2215-2218	e.g	_	_	
11-12	2218-2219	.	_	_	
11-13	2219-2220	,	_	_	
11-14	2221-2229	methanol	_	_	
11-15	2229-2230	,	_	_	
11-16	2231-2242	isopropanol	_	_	
11-17	2242-2243	,	_	_	
11-18	2244-2251	ethanol	_	_	
11-19	2251-2252	,	_	_	
11-20	2253-2261	propanol	_	_	
11-21	2261-2262	,	_	_	
11-22	2263-2270	butanol	_	_	
11-23	2270-2271	,	_	_	
11-24	2272-2282	isobutanol	_	_	
11-25	2282-2283	,	_	_	
11-26	2284-2289	ethyl	_	_	
11-27	2290-2297	butanol	_	_	
11-28	2297-2298	,	_	_	
11-29	2299-2303	amyl	_	_	
11-30	2304-2311	alcohol	_	_	
11-31	2311-2312	)	_	_	
11-32	2312-2313	,	_	_	
11-33	2314-2321	ketones	_	_	
11-34	2321-2322	,	_	_	
11-35	2323-2330	dioxane	_	_	
11-36	2330-2331	,	_	_	
11-37	2332-2340	alkylene	_	_	
11-38	2341-2348	glycols	_	_	
11-39	2348-2349	,	_	_	
11-40	2350-2358	ethylene	_	_	
11-41	2359-2365	glycol	_	_	
11-42	2365-2366	,	_	_	
11-43	2367-2369	or	_	_	
11-44	2370-2382	polyalkylene	_	_	
11-45	2383-2390	glycols	_	_	
11-46	2390-2391	.	_	_	

#Text=Failure to dehydrate the specimen can lead to inadequate impregnation, poor ribbon formation during sectioning, clefts in tissue sections, dissociation of structures, water crystals in tissue sections, and poor staining.
#Text=[0060] Fat in the tissue specimen is removed with a solvent because fat impairs clearing and impregnation.
12-1	2392-2399	Failure	_	_	
12-2	2400-2402	to	_	_	
12-3	2403-2412	dehydrate	_	_	
12-4	2413-2416	the	_	_	
12-5	2417-2425	specimen	_	_	
12-6	2426-2429	can	_	_	
12-7	2430-2434	lead	_	_	
12-8	2435-2437	to	_	_	
12-9	2438-2448	inadequate	_	_	
12-10	2449-2461	impregnation	_	_	
12-11	2461-2462	,	_	_	
12-12	2463-2467	poor	_	_	
12-13	2468-2474	ribbon	_	_	
12-14	2475-2484	formation	_	_	
12-15	2485-2491	during	_	_	
12-16	2492-2502	sectioning	_	_	
12-17	2502-2503	,	_	_	
12-18	2504-2510	clefts	_	_	
12-19	2511-2513	in	_	_	
12-20	2514-2520	tissue	_	_	
12-21	2521-2529	sections	_	_	
12-22	2529-2530	,	_	_	
12-23	2531-2543	dissociation	_	_	
12-24	2544-2546	of	_	_	
12-25	2547-2557	structures	_	_	
12-26	2557-2558	,	_	_	
12-27	2559-2564	water	_	_	
12-28	2565-2573	crystals	_	_	
12-29	2574-2576	in	_	_	
12-30	2577-2583	tissue	_	_	
12-31	2584-2592	sections	_	_	
12-32	2592-2593	,	_	_	
12-33	2594-2597	and	_	_	
12-34	2598-2602	poor	_	_	
12-35	2603-2611	staining	_	_	
12-36	2611-2612	.	_	_	
12-37	2613-2614	[	_	_	
12-38	2614-2618	0060	_	_	
12-39	2618-2619	]	_	_	
12-40	2620-2623	Fat	_	_	
12-41	2624-2626	in	_	_	
12-42	2627-2630	the	_	_	
12-43	2631-2637	tissue	_	_	
12-44	2638-2646	specimen	_	_	
12-45	2647-2649	is	_	_	
12-46	2650-2657	removed	_	_	
12-47	2658-2662	with	_	_	
12-48	2663-2664	a	_	_	
12-49	2665-2672	solvent	_	_	
12-50	2673-2680	because	_	_	
12-51	2681-2684	fat	_	_	
12-52	2685-2692	impairs	_	_	
12-53	2693-2701	clearing	_	_	
12-54	2702-2705	and	_	_	
12-55	2706-2718	impregnation	_	_	
12-56	2718-2719	.	_	_	

#Text=Inadequate fat removal can result in spreading artifacts of tissue sections, wrinkling of tissue sections, and poor staining.
13-1	2720-2730	Inadequate	_	_	
13-2	2731-2734	fat	_	_	
13-3	2735-2742	removal	_	_	
13-4	2743-2746	can	_	_	
13-5	2747-2753	result	_	_	
13-6	2754-2756	in	_	_	
13-7	2757-2766	spreading	_	_	
13-8	2767-2776	artifacts	_	_	
13-9	2777-2779	of	_	_	
13-10	2780-2786	tissue	_	_	
13-11	2787-2795	sections	_	_	
13-12	2795-2796	,	_	_	
13-13	2797-2806	wrinkling	_	_	
13-14	2807-2809	of	_	_	
13-15	2810-2816	tissue	_	_	
13-16	2817-2825	sections	_	_	
13-17	2825-2826	,	_	_	
13-18	2827-2830	and	_	_	
13-19	2831-2835	poor	_	_	
13-20	2836-2844	staining	_	_	
13-21	2844-2845	.	_	_	

#Text=Fat may be removed from the tissue specimen with an organic solvent such as, for example, acetone, chloroform or xylene.
#Text=[0061] Optionally, the tissue specimen is cleared.
14-1	2846-2849	Fat	_	_	
14-2	2850-2853	may	_	_	
14-3	2854-2856	be	_	_	
14-4	2857-2864	removed	_	_	
14-5	2865-2869	from	_	_	
14-6	2870-2873	the	_	_	
14-7	2874-2880	tissue	_	_	
14-8	2881-2889	specimen	_	_	
14-9	2890-2894	with	_	_	
14-10	2895-2897	an	_	_	
14-11	2898-2905	organic	_	_	
14-12	2906-2913	solvent	_	_	
14-13	2914-2918	such	_	_	
14-14	2919-2921	as	_	_	
14-15	2921-2922	,	_	_	
14-16	2923-2926	for	_	_	
14-17	2927-2934	example	_	_	
14-18	2934-2935	,	_	_	
14-19	2936-2943	acetone	_	_	
14-20	2943-2944	,	_	_	
14-21	2945-2955	chloroform	_	_	
14-22	2956-2958	or	_	_	
14-23	2959-2965	xylene	_	_	
14-24	2965-2966	.	_	_	
14-25	2967-2968	[	_	_	
14-26	2968-2972	0061	_	_	
14-27	2972-2973	]	_	_	
14-28	2974-2984	Optionally	_	_	
14-29	2984-2985	,	_	_	
14-30	2986-2989	the	_	_	
14-31	2990-2996	tissue	_	_	
14-32	2997-3005	specimen	_	_	
14-33	3006-3008	is	_	_	
14-34	3009-3016	cleared	_	_	
14-35	3016-3017	.	_	_	

#Text=The clearant extracts solvents used for dehydrating and/or defatting from the tissue specimen if they are not miscible with the impregnating agent.
15-1	3018-3021	The	_	_	
15-2	3022-3030	clearant	_	_	
15-3	3031-3039	extracts	_	_	
15-4	3040-3048	solvents	_	_	
15-5	3049-3053	used	_	_	
15-6	3054-3057	for	_	_	
15-7	3058-3069	dehydrating	_	_	
15-8	3070-3073	and	_	_	
15-9	3073-3074	/	_	_	
15-10	3074-3076	or	_	_	
15-11	3077-3086	defatting	_	_	
15-12	3087-3091	from	_	_	
15-13	3092-3095	the	_	_	
15-14	3096-3102	tissue	_	_	
15-15	3103-3111	specimen	_	_	
15-16	3112-3114	if	_	_	
15-17	3115-3119	they	_	_	
15-18	3120-3123	are	_	_	
15-19	3124-3127	not	_	_	
15-20	3128-3136	miscible	_	_	
15-21	3137-3141	with	_	_	
15-22	3142-3145	the	_	_	
15-23	3146-3158	impregnating	_	_	
15-24	3159-3164	agent	_	_	
15-25	3164-3165	.	_	_	

#Text=The tissue may become "clear" and its opacity may be reduced due to this extraction.
16-1	3166-3169	The	_	_	
16-2	3170-3176	tissue	_	_	
16-3	3177-3180	may	_	_	
16-4	3181-3187	become	_	_	
16-5	3188-3189	"	_	_	
16-6	3189-3194	clear	_	_	
16-7	3194-3195	"	_	_	
16-8	3196-3199	and	_	_	
16-9	3200-3203	its	_	_	
16-10	3204-3211	opacity	_	_	
16-11	3212-3215	may	_	_	
16-12	3216-3218	be	_	_	
16-13	3219-3226	reduced	_	_	
16-14	3227-3230	due	_	_	
16-15	3231-3233	to	_	_	
16-16	3234-3238	this	_	_	
16-17	3239-3249	extraction	_	_	
16-18	3249-3250	.	_	_	

#Text=Examples of clearants include xylene, limonene, benzene, toluene, chloroform, petroleum ether, carbon bisulfide, carbon tetrachloride, dioxane, clove oil, or cedar oil.
17-1	3251-3259	Examples	_	_	
17-2	3260-3262	of	_	_	
17-3	3263-3272	clearants	_	_	
17-4	3273-3280	include	_	_	
17-5	3281-3287	xylene	_	_	
17-6	3287-3288	,	_	_	
17-7	3289-3297	limonene	_	_	
17-8	3297-3298	,	_	_	
17-9	3299-3306	benzene	_	_	
17-10	3306-3307	,	_	_	
17-11	3308-3315	toluene	_	_	
17-12	3315-3316	,	_	_	
17-13	3317-3327	chloroform	_	_	
17-14	3327-3328	,	_	_	
17-15	3329-3338	petroleum	_	_	
17-16	3339-3344	ether	_	_	
17-17	3344-3345	,	_	_	
17-18	3346-3352	carbon	_	_	
17-19	3353-3362	bisulfide	_	_	
17-20	3362-3363	,	_	_	
17-21	3364-3370	carbon	_	_	
17-22	3371-3384	tetrachloride	_	_	
17-23	3384-3385	,	_	_	
17-24	3386-3393	dioxane	_	_	
17-25	3393-3394	,	_	_	
17-26	3395-3400	clove	_	_	
17-27	3401-3404	oil	_	_	
17-28	3404-3405	,	_	_	
17-29	3406-3408	or	_	_	
17-30	3409-3414	cedar	_	_	
17-31	3415-3418	oil	_	_	
17-32	3418-3419	.	_	_	
